Questions remain over COX-2 advertising

February 23 2005

Although an FDA Advisory panel has voted for Merck’s Vioxx and Pfizer’s Celebrex and Bextra to stay on the market, ...

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.